Cancer Epidemiology, Biomarkers and Prevention

Journal

Publication Venue For

  • Persistent Child Poverty and Mortality in a Cohort of Children with Cancer in Alabama.  32:380-386. 2023
  • Healthcare Access Domains Mediate Racial Disparities in Ovarian Cancer Treatment Quality in a US Patient Cohort: A Structural Equation Modelling Analysis.  32:74-81. 2023
  • Predicting Postallogeneic Hematopoietic Cell Transplant Glucose Intolerance: The Role of CT-based Body Composition.  31:2002-2003. 2022
  • Genome-Wide Association Study of Pregnancy in Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study.  31:1858-1862. 2022
  • Leveraging Clinical Trial Populations and Data from the Children’s Oncology Group for Cancer Survivorship Research.  31:1675-1682. 2022
  • Associations of Healthcare Affordability, Availability, and Accessibility with Quality Treatment Metrics in Patients with Ovarian Cancer.  31:1383-1393. 2022
  • B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS.  31:1103-1110. 2022
  • Examining the Association of Food Insecurity and Being Up-to-Date for Breast and Colorectal Cancer Screenings.  31:1017-1025. 2022
  • Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children’s Oncology Group.  31:536-542. 2022
  • Examining Rural-Urban Differences in Fatalism and Information Overload: Data from 12 NCI-Designated Cancer Centers.  31:393-403. 2022
  • Short NK- and Naïve T-Cell Telomere Length Is Associated with Thyroid Cancer in Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study.  31:453-460. 2022
  • Expenditures in Young Adults with Hodgkin Lymphoma: NCI-Designated Comprehensive Cancer Centers versus Other Sites.  31:142-149. 2022
  • Functional Outcomes and Social Attainment in Asian/ Pacific Islander Childhood Cancer Survivors in the United States: A Report from the Childhood Cancer Survivor Study.  30:2244-2255. 2021
  • Polygenic risk score improves risk stratification and prediction of subsequent thyroid cancer after childhood cancer.  30:2096-2104. 2021
  • Tumor necrosis factor inhibitors and the risk of cancer among older Americans with rheumatoid arthritis.  30:2059-2067. 2021
  • Reducing poverty-related disparities in cervical cancer: The role of HPV vaccination.  30:1895-1903. 2021
  • Abstract 107: Self-Reported Physical Activity Patterns among Colorectal Cancer Survivors in Egypt.  30:107-107. 2021
  • Abstract 22: Screening and Treatment of Female Sex Workers for Cervical Precancers in Cameroon.  30:22-22. 2021
  • Abstract 59: Examining a Culturally Relevant Intervention to Promote Colorectal Cancer Screening in Egypt.  30:59-59. 2021
  • Cost-effectiveness of offering cervical cancer screening with HPV self-sampling among african-American women in the mississippi delta.  30:1114-1121. 2021
  • Associations of Novel Dietary and Lifestyle Inflammation Scores with Incident, Sporadic Colorectal Adenoma.  29:2300-2308. 2020
  • Body composition, metabolic health, and functional impairment among adults treated for abdominal and pelvic tumors during childhood.  29:1750-1758. 2020
  • Patterns and disparities in human papillomavirus (HPV) vaccine uptake for young female adolescents among U.S. States: NIS-teen (2008–2016).  29:1458-1467. 2020
  • Urban versus rural residence and outcomes in older patients with breast cancer.  29:1313-1320. 2020
  • Circulating Antibodies against Epstein Barr Virus (EBV) and p53 in EBV-positive and -negative gastric cancer.  29:414-419. 2020
  • A renewed focus on health disparities in the year 2020: Reexamining geospatial disparities.  29:2107-2108. 2020
  • A serum-induced transcriptome and serum cytokine signature obtained at diagnosis correlates with the development of early pancreatic ductal adenocarcinoma metastasis.  28:680-689. 2019
  • Telomere length-associated genetic variants and the risk of thyroid cancer in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS).  28:417-419. 2019
  • Methylation of high-risk human papillomavirus genomes are associated with cervical precancer in HIV-positive women.  27:1407-1415. 2018
  • Causes of inferior outcome in adolescents and young adults with acute lymphoblastic leukemia: Across oncology services and regardless of clinical trial enrollment.  27:1133-1141. 2018
  • The obesity paradox in cancer-moving beyond BMI-response.  26:981. 2017
  • Young adult and usual adult body mass index and multiple myeloma risk: A pooled analysis in the international multiple myeloma consortium (IMMC).  26:876-885. 2017
  • Adolescents and young adults with acute lymphoblastic leukemia and acute myeloid leukemia: Impact of care at specialized cancer centers on survival outcome.  26:312-320. 2017
  • The obesity paradox in cancer-moving beyond BMI.  26:13-16. 2017
  • A meta-analysis of multiple myeloma risk regions in African and European ancestry populations identifies putatively functional loci.  25:1609-1618. 2016
  • Association between body powder use and ovarian cancer: The African American Cancer Epidemiology Study (AACES).  25:1411-1417. 2016
  • Overtreatment and cost-effectiveness of the see-and-treat strategy for managing cervical precancer.  25:807-814. 2016
  • Quality of physician communication about HPV vaccine-letter.  25:867. 2016
  • Performance of three-biomarker immunohistochemistry for intrinsic breast cancer subtyping in the AMBER consortium.  25:470-478. 2016
  • Differential inequality trends over time in survival among U.S. children with acute lymphoblastic leukemia by race/ethnicity, age at diagnosis, and sex.  24:1781-1785. 2015
  • Symptoms, weight loss and physical function in a lifestyle intervention study of older cancer survivors..  24:763-764. 2015
  • Abstract C77: Tristetraprolin suppression is associated with advanced stage colorectal cancer.  23:c77-c77. 2014
  • Abstract PR5: Prognostic value of miRNAs in breast cancer: Molecular type and patient race.  23:pr5-pr5. 2014
  • Accelerometer determined lifestyle behaviors over time - Letter.  23:6212. 2014
  • Accelerometer determined lifestyle behaviors over time-letter.  23:2612. 2014
  • Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease.  23:1997-2008. 2014
  • Better postdiagnosis diet quality is associated with reduced risk of death among postmenopausal women with invasive breast cancer in the women's health initiative.  23:575-583. 2014
  • Carnitine and cardiac dysfunction in childhood cancer survivors treated with anthracyclines.  23:1109-1114. 2014
  • Oxidative balance score, colorectal adenoma, and markers of oxidative stress and inflammation.  23:545-554. 2014
  • Low-fat diet and skin cancer risk: The women's health initiative randomized controlled dietary modification trial.  22:1509-1519. 2013
  • The role of obesity in cancer survival and recurrence.  21:1244-1259. 2012
  • TLE3 expression is associated with sensitivity to taxane treatment in ovarian carcinoma.  21:273-279. 2012
  • Sex hormones, hormonal interventions, and gastric cancer risk: A meta-analysis.  21:20-38. 2012
  • Cancer survivorship: Focusing on future research opportunities.  20:1994-1995. 2011
  • Impact of survivorship-based research on defining clinical care guidelines.  20:2085-2092. 2011
  • Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors.  20:2048-2067. 2011
  • Serum selenium, genetic variation in selenoenzymes, and risk of colorectal cancer: Primary analysis from the women's health initiative observational study and meta-analysis.  20:1822-1830. 2011
  • Conducting cancer control and survivorship research via cooperative groups: A report from the American Society of Preventive Oncology.  20:1050-1055. 2011
  • Predictors and Health Consequences of Epigenetic Changes Associated with Excess Body Weight in Women of Child-bearing Age.  20:719-719. 2011
  • Obesity and thyroid cancer risk among U.S. men and women: A pooled analysis of five prospective studies.  20:464-472. 2011
  • Scientific bias arising from sampling, selective recruitment, and attrition: The case for improved reporting.  20:415-418. 2011
  • Alcohol consumption and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women.  19:2066-2072. 2010
  • Adolescent diet and subsequent serum hormones, breast density, and bone mineral density in young women: Results of the dietary intervention study in children follow-up study.  19:1545-1556. 2010
  • A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer.  18:2046-2053. 2009
  • How to efficiently obtain human tissues to support specific biomedical research projects.  18:1676-1679. 2009
  • Physical activity and health outcomes three months after completing a physical activity behavior change intervention: Persistent and delayed effects.  18:1410-1418. 2009
  • The association of bone mineral density with prostate cancer risk in the osteoporotic fractures in men (MrOS) study.  18:148-154. 2009
  • Flaxseed Supplementation (Not Dietary Fat Restriction) Reduces Prostate Cancer Proliferation Rates in Men Presurgery.  17:3577-3587. 2008
  • Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery.  17:3577-3587. 2008
  • Risk factors for classical Kaposi sarcoma in a population-based case-control study in sicily.  17:3435-3443. 2008
  • Conjugated equine estrogens and colorectal cancer incidence and survival: The women's health initiative randomized clinical trial.  17:2609-2618. 2008
  • Strategies to maximize the competitiveness of cancer survivorship grant applications: A report from the American Society of Preventive Oncology's Survivorship Interest Group.  17:2899-2900. 2008
  • Metastatic gastrointestinal stromal tumors in the era of imatinib: Improved survival and elimination of socioeconomic survival disparities.  17:2194-2201. 2008
  • Cancer survivorship research: Opportunities and future needs for expanding the research base.  17:1551-1557. 2008
  • Successful coordination and execution of nontherapeutic studies in a cooperative group setting: Lessons learned from children's oncology group studies.  17:1665-1673. 2008
  • Differences in baseline characteristics and outcomes at 1- and 2-year follow-up of cancer survivors accrued via self-referral versus cancer registry in the FRESH START diet and exercise trial.  17:1288-1294. 2008
  • Chemoprevention of prostate cancer through dietary agents: Progress and promise.  16:2193-2203. 2007
  • Interleukin-10 gene (IL10) polymorphisms and human papillomavirus clearance among immunosuppressed adolescents.  16:1626-1632. 2007
  • Health care utilization by adult long-term survivors of hematopoietic cell transplant: Report from the bone marrow transplant survivor study.  16:834-839. 2007
  • Overweight and obese perimenopausal and postmenopausal women exhibit increased abnormal mammary epithelial cytology.  16:613-616. 2007
  • Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases.  16:532-537. 2007
  • Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity.  15:926-934. 2006
  • Results from project LEAD (Leading the way in Exercise And Diet): A lifestyle intervention trial aimed at older adults diagnosed with breast and prostate cancer..  14:2809S-2809S. 2005
  • Positive and negative associations of human leukocyte antigen variants with the onset and prognosis of adult glioblastoma multiforme.  14:2040-2044. 2005
  • Catechol-O-methyl-transferase functional polymorphism and nicotine dependence: An evaluation of nonreplicated results.  14:1384-1389. 2005
  • α-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis.  14:1418-1423. 2005
  • Response rates to a mailed survey targetting childhood cancer survivors: A comparison of conditional versus unconditional incentives.  14:1330-1332. 2005
  • A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma.  14:633-637. 2005
  • Associations between lifestyle practices and quality of life among breast and prostate cancer survivors screened for the FRESH START trial.  14:548-548. 2005
  • IGF1 (CA) 19 repeat and IGFBP3 -202 A/C genotypes and the risk of prostate cancer in Black and White men.  14:403-408. 2005
  • Accrual into the FRESH START diet and exercise trial for cancer survivors: Comparison of self-referred versus cancer registry solicited samples with regard to health behavior and socio-demographic factors..  13:1937S-1937S. 2004
  • Childhood cancer survivors: Health behaviors and receptivity to health promotion interventions..  13:1939S-1939S. 2004
  • Associations between two common variants C677T and A1298C in the methylenetetrahydrofolate reductase gene and of measures of folate metabolism and DNA stability (strand breaks, misincorporated uracil, and DNA methylation status) in human lymphocytes in vivo.  13:1436-1443. 2004
  • No Difference in Response Rate to a Mailed Survey among Prostate Cancer Survivors Using Conditional versus Unconditional Incentives.  13:277-278. 2004
  • Assessing eligibility among cancer survivors for participation in a lifestyle intervention study..  12:1278S-1278S. 2003
  • Interventions for cancer survivors: Capitalizing on a teachable moment.  12:1369S-1369S. 2003
  • Lifestyle changes for cancer prevention in older adults.  12:1361S-1362S. 2003
  • Branched fatty acids in dairy and beef products markedly enhance α-methylacyl-CoA racemase expression in prostate cancer cells in vitro.  12:775-783. 2003
  • Imsulin-like growth factor-1 (IGF-1): An exploration of serum levels, binding protein (IGFBP-3) and IGF-1 CA repeat genotype, and the risk of prostae cancer.  12:182-182. 2003
  • The efficacy of 9-Cis-retinoic acid (aliretinoin) as a chemopreventive agent for cervical dysplasia: Results of a randomized double-blind clinical trial.  12:114-119. 2003
  • Effects of a low fat, flaxseed-supplemented diet on men with prostatic intraepithelial neoplasia (PIN) or atypia..  11:1171S-1171S. 2002
  • Correspondence re: E. Hawk, et al., Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first national health and nutrition examination survey. Cancer epidemiol. Biomark. Prev., 9: 523-527, 2000 [1] (multiple letters).  10:415-416. 2001
  • Early onset baldness and prostate cancer risk.  9:325-328. 2000
  • Effect of short-term flaxseed supplementation and fat modification in men with prostate cancer.  9:235-235. 2000
  • Increased weight & body fatness associated with chemotherapy for breast cancer ... & what can be done?.  9:236-236. 2000
  • Validity of self-reported colorectal cancer screening behavior.  9:229-232. 2000
  • Environmental contaminants and body fat distribution.  8:179-183. 1999
  • Moderate physical activity in relation to mammographic patterns.  8:117-122. 1999
  • Hypomethylation in cervical tissue: Is there a correlation with folate status?.  7:901-906. 1998
  • 1α,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells.  6:727-732. 1997
  • 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells..  6:727-732. 1997
  • Urinary phytoestrogen levels in young women from a multiethnic population.  6:339-345. 1997
  • Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women.  5:785-794. 1996
  • Cigarette Smoking, Intracellular Vitamin Deficiency, and Occurrence of Micronuclei in Epithelial Cells of the Buccal Mucosa.  4:751-758. 1995
  • Red Cell and Plasma Folate, Folate Consumption, and the Risk of Colorectal Adenomatous Polyps.  4:709-714. 1995
  • Questionnaire Assessment of Intake of Specific Carotenoids.  4:201-205. 1995
  • International Standard Serial Number (issn)

  • 1055-9965
  • Electronic International Standard Serial Number (eissn)

  • 1538-7755